Drugs & Pharmaceuticals M&A » By The Online Investor Staff, updated Fri., Apr. 26, 1:27 PM
Recent mergers and acquisitions in the Drugs & Pharmaceuticals M&A category.
Slide #3. H. Lundbeck A/S (Lundbeck) — Chelsea Therapeutics International, Ltd.
Acquirer: |
H. Lundbeck A/S (Lundbeck) |
Acquiree: |
Chelsea Therapeutics International, Ltd. (CHTP) |
Details: |
Chelsea Therapeutics International, Ltd. (Chelsea) (Nasdaq:CHTP), a biopharmaceutical development company, has entered into a definitive agreement to be acquired by H. Lundbeck A/S (Lundbeck) (LUN.CO) (LUN DC) (HLUYY), a global pharmaceutical company that specializes in brain diseases. The details of this transaction can be found in the joint press release issued by the two companies. |
Open the CHTP Page at The Online Investor »
Open the CHTP Page at The Online Investor (in a new window) »
|
April 26, 2024 1:27 PM Eastern
Hold (2.00 out of 4)
100th percentile
|
|